The Lignan-containing Extract of Schisandra chinensis Berries Inhibits the Growth of Chlamydia pneumonia

Nat Prod Commun. 2015 Jun;10(6):1001-4.

Abstract

The purpose of this study was to investigate the effect and selectivity of an extract of Schisandra chinensis berries against Chlamydia pneumoniae and C. trachomatis. Among the ethnopharmacological uses of the extract from Schisandrae fructus are cough and pneumonia. Therefore we focused on respiratory pathogens. The extract completely inhibited the growth of C. pneumoniae strain CV6 at 250 μg/mL concentration. The inhibition of C. pneumoniae and C. trachomatis growth was dose dependent and established with three different strains. The extract inhibited C. pneumoniae production of infectious progeny in a dose dependent manner. Chlamydia selectivity was elucidated with growth inhibition measurements of three other respiratory bacterial species. A pure compound found in Schisandra chinensis berries, schisandrin B at 20.0 μg/mL concentration inhibited the growth of both C. pneumoniae and C. trachomatis. The extract was found to be non-toxic to the human host cells. These findings highlight the potential of the extract from Schisandra chinensis berries as a source for antichlamydial compounds.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chlamydia / drug effects*
  • Chlamydia / growth & development
  • Chlamydia Infections / microbiology
  • Fruit / chemistry
  • HeLa Cells
  • Humans
  • Lignans / chemistry*
  • Lignans / pharmacology*
  • Plant Extracts / chemistry
  • Plant Extracts / pharmacology*
  • Schisandra / chemistry*

Substances

  • Lignans
  • Plant Extracts